Document is current
Any future updates will be listed below
-
Authors
Julian, Elaine
Gianfrate, Fabrizio http://orcid.org/0000-0003-0513-0894
Sola-Morales, Oriol http://orcid.org/0000-0002-8312-8178
Mol, Peter http://orcid.org/0000-0002-4262-3180
Bergmann, Jean-François http://orcid.org/0000-0001-6861-9748
Salmonson, Tomas
Hebborn, Ansgar
Grande, Mathilde
Ruof, Jörg http://orcid.org/0000-0001-8706-934X
-
Funding
Funding for this research was provided by:
F. Hoffmann-La Roche
AbbVie
Sanofi
Novartis
- License Information
-
More Information
Article History
Received: 15 April 2022
Accepted: 27 May 2022
First Online: 2 June 2022
Declarations
:
: Not applicable.
: Not applicable.
: JR & EJ received an unrestricted grant by Roche, Novartis, Abbvie, and Sanofi that partially funded this research.PM: no CoI.FG: no CoI.JFB received honoraria for consulting and research grants from Abbvie, Amgen, AstraZeneca, Bayer, BMS, Ferring, Gilead, GSK, IQVIA, Lilly, Novartis, Roche, Sanofi, Takeda.MGR: no CoI.OSM: no COI.TS: no CoI.AH: employed by F. Hoffmann-La Roche
